Log in to save to my catalogue

10 Enhancing the therapeutic responses of anti-human CCR8 mAbs utilizing the fully humanized CCR8 kn...

10 Enhancing the therapeutic responses of anti-human CCR8 mAbs utilizing the fully humanized CCR8 kn...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a2afc87b8b5548f8a31a004a90065d8d

10 Enhancing the therapeutic responses of anti-human CCR8 mAbs utilizing the fully humanized CCR8 knockin mice

About this item

Full title

10 Enhancing the therapeutic responses of anti-human CCR8 mAbs utilizing the fully humanized CCR8 knockin mice

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A10-A10

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundDepletion of tumor-resident CCR8+ Treg cells has been demonstrated remarkable antitumor effects. A few hCCR8-targeted therapeutic antibodies have been developed and are now undergone clinical testing in patients with advanced or metastatic solid tumors. However, the challenge remains in preclinical evaluation for human-specific CCR8 mAbs...

Alternative Titles

Full title

10 Enhancing the therapeutic responses of anti-human CCR8 mAbs utilizing the fully humanized CCR8 knockin mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a2afc87b8b5548f8a31a004a90065d8d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a2afc87b8b5548f8a31a004a90065d8d

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2023-SITC2023.0010

How to access this item